Longeveron Achieves Milestone in Groundbreaking Stem Cell Trial for Alzheimer’s Disease – Yahoo Finance
|
Longeveron Achieves Milestone in Groundbreaking Stem Cell Trial for Alzheimer's Disease
Yahoo Finance MIAMI, March 15, 2017 /PRNewswire/ — Longeveron, a leading stem cell research company focused on biological solutions for age-associated diseases, announced today the successful completion of enrollment in the first phase of its clinical research … |
